Acadia Healthcare Company Inc (ACHC) was Reiterated by Mizuho to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 71 from a previous price target of $66 . Mizuho advised their investors in a research report released on Apr 29, 2016.
Many Wall Street Analysts have commented on Acadia Healthcare Company Inc. Shares were Reiterated by Jefferies on Feb 17, 2016 to “Buy” and Lowered the Price Target to $ 85 from a previous price target of $100 .Acadia Healthcare Company Inc was Initiated by KeyBanc Capital Mkts to “Overweight” on Feb 1, 2016.
On the company’s financial health, Acadia Healthcare Company Inc reported $0.59 EPS for the quarter, based on the information available during the earnings call on Feb 16, 2016. Analyst had a consensus estimate of $0.59. The company had revenue of $495.30 million for the quarter, compared to analysts expectations of $486.25 million. The company’s revenue was up 68.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.46 EPS.
Acadia Healthcare Company Inc opened for trading at $63.42 and hit $64.09 on the upside on Wednesday, eventually ending the session at $63.73, with a gain of 0.54% or 0.34 points. The heightened volatility saw the trading volume jump to 10,24,910 shares. Company has a market cap of $5,559 M.
In a different news, on Aug 18, 2015, David M. Duckworth (Chief Financial Officer) sold 31,129 shares at $80.47 per share price. According to the SEC, on Aug 18, 2015, Ronald Morgan Fincher (Chief Operating Officer) sold 37,294 shares at $80.47 per share price. On Aug 18, 2015, Christopher L Howard (EVP, GC and Secretary) sold 36,141 shares at $80.47 per share price, according to the Form-4 filing with the securities and exchange commission.
Acadia Healthcare Company Inc. is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities residential treatment centers group homes substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities. It operates in two segments: U.S. Facilities and U.K. Facilities. Its U.S. Facilities and services are classified into categories which includes acute inpatient psychiatric facilities; specialty treatment facilities; residential treatment centers; and outpatient community-based services. In the United Kingdom it provides inpatient services through mental health hospitals and care homes. In addition to these services it also operates a U.K. division to provide EAP to organizations. The Company operated approximately 78 behavioral healthcare facilities with over 5800 beds in approximately 24 states the United Kingdom and Puerto Rico.